Federal Circuit confirms Biogen’s multi-billion dollar Tecfidera patent disaster
In a split decision, the CAFC has upheld a decision that cut short the exclusivity of the company’s best-selling product by eight years
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.